Contineum Therapeutics (CTNM) IPO deck
Ontineum Therapeutics is advancing precision small molecule therapies for neurology, inflammation, and immunology diseases with high unmet needs.
Ontineum Therapeutics is advancing precision small molecule therapies for neurology, inflammation, and immunology diseases with high unmet needs.
%20IPO%20deck){kind=link}